KRISTA SPALDING: Open Payments
NPI 1033727979 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 30 payments from 16 companies in 2025. Trend: 2023 $1,565 · 2024 $1,148 · 2025 $1,060
Food & beverage: $960Education: $100
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 2 | $277 |
| Galderma Laboratories, L.P. | 4 | $177 |
| AstraZeneca Pharmaceuticals LP | 6 | $140 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| United Therapeutics Corporation | 3 | $79 |
| Insmed, Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| ABBVIE INC. | 2 | $35 |
| GENZYME CORPORATION | 1 | $32 |
| Baxter Healthcare | 1 | $31 |
Products named: DAXXIFY, DUPIXENT, Tyvaso, AIRSUPRA, FASENRA, TEZSPIRE, Arikayce, NUCALA.
Industry payments across IN — which companies pay providers there.
